tiprankstipranks
BioMarin Pharmaceutical (DE:BM8)
FRANKFURT:BM8
Holding DE:BM8?
Track your performance easily

BioMarin Pharmaceutical (BM8) Cash flow

2 Followers

BioMarin Pharmaceutical Cash Flow

DE:BM8's free cash flow for Q3 2024 was $200.31M. For the 2024 fiscal year, DE:BM8's free cash flow was decreased by $7.29M and operating cash flow was $221.48M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 414.70M$ 159.26M$ 175.90M$ 304.54M$ 80.86M$ 43.06M
Investing Cash Flow
$ -4.88M$ -111.24M$ -20.03M$ -366.31M$ -49.12M$ -25.82M
Financing Cash Flow
$ -518.47M$ -18.73M$ -18.65M$ -48.00K$ 181.12M$ -74.67M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 3.15B$ 755.13M$ 724.53M$ 587.28M$ 649.16M$ 437.45M
Income Tax Paid Supplemental Data
$ 57.71M$ 73.31M$ 54.37M$ 18.15M$ 8.98M$ 9.73M
Interest Paid Supplemental Data
$ 10.32M$ 10.30M$ 10.28M$ 10.39M$ 12.18M$ 8.55M
Issuance Of Capital Stock
------
Issuance Of Debt
$ -495.03M$ -2.29M$ -2.60M$ -3.04M$ 203.84M-
Repayment Of Debt
$ -495.03M$ -2.29M$ -2.60M$ -3.04M$ -381.91M-
Free Cash Flow
$ 300.88M$ 51.65M$ 44.36M$ 185.31M$ -56.65M$ -120.35M
Domestic Sales
------
Foreign Sales
------
Currency in USD

BioMarin Pharmaceutical Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis